Method for researching differentially expressed proteins of triple negative breast cancer exosomes by using iTRAQ technology

A triple-negative breast cancer, differentially expressed protein technology, applied in measurement devices, instruments, scientific instruments, etc., to achieve the effect of large throughput and high identification accuracy

Active Publication Date: 2018-12-21
重庆问创基因科技有限公司
View PDF6 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Then, can the application of iTRAQ technology to study the differentially expressed proteins in blood exosomes of patients with triple-negative breast cancer provide a reference for the disease mechanism of triple-negative...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for researching differentially expressed proteins of triple negative breast cancer exosomes by using iTRAQ technology
  • Method for researching differentially expressed proteins of triple negative breast cancer exosomes by using iTRAQ technology
  • Method for researching differentially expressed proteins of triple negative breast cancer exosomes by using iTRAQ technology

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0045] The present invention will be described in further detail below in conjunction with the accompanying drawings and specific embodiments.

[0046] In the embodiment of the present invention, the present invention provides a method of applying iTRAQ technology to study differentially expressed proteins in triple-negative breast cancer exosomes.

[0047] Unless otherwise specified in the examples of the present invention, all reagents and consumables used are commercially available.

[0048] 1 Materials and methods

[0049] 1.1 Sample preparation (model building)

[0050] Three groups of blood samples, among them, the experimental group A is the blood samples of patients with triple-negative breast cancer, the control group B is the blood samples of HER2-positive breast cancer patients, and the control group C is the blood samples of normal people, in which the experimental group A has three samples, and the control group Three samples of group B, two samples of control g...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method for researching differentially expressed proteins of triple negative breast cancer exosomes by using an iTRAQ technology. The method comprises the following steps of (1) extracting and treating exosomes and exosome proteins; (2) carrying out enzymatic hydrolysis and desalination on exosome protein samples obtained in the step (1) to obtain polypeptides; (3) carrying out iTRAQ labelling and mixing on the polypeptides obtained in the step (2); (4) carrying out HPLC separation and LC-MS analysis on a polypeptide-peptide mixture labelled in the step (3); and (5) carrying out bioinformatics analysis and quantitative analysis on the obtained mass spectrometry identification result to obtain the differentially expressed proteins of the triple negative breast cancer exosomes. Research on triple negative breast cancer exosome proteome can be quickly and effectively carried out by combining the iTRAQ technology disclosed by the invention with an MS/MS technology,and a reference is provided for researching a disease mechanism of a triple negative breast cancer and discovering triple negative breast cancer-related biomarkers.

Description

technical field [0001] The invention relates to the field of triple-negative breast cancer, in particular to a method for studying differentially expressed proteins in exosomes of triple-negative breast cancer by applying iTRAQ technology. Background technique [0002] Triple-negative breast cancer (TNBC) refers to estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (human epidermal growth factor receptor 2). Receptor 2, Her2) are not expressed in a type of breast cancer, which has the characteristics of younger onset, high degree of malignancy, strong invasiveness, only part of which is sensitive to radiotherapy and chemotherapy, and has the characteristics of difficult treatment and easy recurrence. The peak period of recurrence is within a year, and most patients die in the first 5 years of treatment, which is one of the most difficult subtypes of breast cancer treatment. The pathogenic mechanism and interacting proteins of tri...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N30/02G01N30/06
CPCG01N30/02G01N30/06
Inventor 李丽仙郑晓东辇伟奇廖斌杨薇伍青庞才双
Owner 重庆问创基因科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap